There is great interest in developing naturally-derived compounds especially bioactive peptides with potential insulin sensitizing effects and/or preventing insulin resistance. Previously， we showed adipogenic and insulin mimetic actions of IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro)， the milk-derived tripeptides on cultured pre-adipocytes， in addition to their previously characterized anti-hypertensive and anti-inflammatory functions. However， the effect of these peptides on insulin signaling is not known. Therefore， we examined IPP and VPP effects on insulin signaling in pre-adipocytes， a well-established model for studying insulin signaling. Our results suggested both peptides enhanced insulin signal... More
There is great interest in developing naturally-derived compounds especially bioactive peptides with potential insulin sensitizing effects and/or preventing insulin resistance. Previously， we showed adipogenic and insulin mimetic actions of IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro)， the milk-derived tripeptides on cultured pre-adipocytes， in addition to their previously characterized anti-hypertensive and anti-inflammatory functions. However， the effect of these peptides on insulin signaling is not known. Therefore， we examined IPP and VPP effects on insulin signaling in pre-adipocytes， a well-established model for studying insulin signaling. Our results suggested both peptides enhanced insulin signaling and contributed towards the prevention of insulin resistance in the presence of tumor necrosis factor (TNF). Inhibition of inflammatory mediator NF-kB under TNF stimulation was a likely contributor to the prevention of insulin resistance. VPP further enhanced the expression of glucose transporter 4 (GLUT4) in adipocytes and restored glucose uptake in TNF-treated adipocytes. Our data suggested the potential of these peptides in the management of conditions associated with impairments in insulin signaling.
